Thanks to an innovative system of magnetic microcapsule separation, the Nanobiocel-CIBER BNN research group of the UPV/EHU-University of the Basque Country in collaboration with the BIOMICS group, also of the UPV/EHU, has managed to reduce the volume of microcapsule implants containing insulin-producing pancreatic cells by nearly 80%. That way, the medical complications arising out of implanting large volumes of microcapsules are reduced and the treatment of type 1 diabetes mellitus is improved.
